(Q57756401)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Liver cancer: Effect of HCV clearance with direct-acting antiviral agents on HCC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Augusto Villanueva

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Augusto Villanueva

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

561-562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2016.140

22 March 2020

exact match

0 references

cites work

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.140

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27580683

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27580683

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2016.140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27580683%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference